Tomofumi Ando

Tomofumi Ando

Publications

Hide

Liu X, Liu Z, Zhu C, Kobayashi T, Lei PJ, Shi Y, Yuan D, Wang J, Li M, Matsui A, Mafra K, Ando T, Kojo K, Schleinhege R, Miyazaki K, Huang P, Kuang M, Bod L, Duda DG

Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.
Nat Commun. 2025;16(1):10416 - PMID: 41360802 - PMCID: PMC12686393 - DOI: 10.1038/s41467-025-66581-3

Morita S, Lei PJ, Shigeta K, Ando T, Kobayashi T, Kikuchi H, Matsui A, Huang P, Pittet MJ, Duda DG

Combination CXCR4 and PD1 blockade enhances intratumoral dendritic cell activation and immune responses against hepatocellular carcinoma.
Cancer Immunol Res. 2024;13(2):162-170 - PMID: 39514263 - PMCID: PMC11788650 - DOI: 10.1158/2326-6066.CIR-24-0324